Google DeepMind Unveils AlphaGenome to Decode Genetic Causes of Disease

Google DeepMind launched AlphaGenome, an AI tool designed to identify genetic drivers of disease.
The system predicts how DNA mutations disrupt gene regulation across different cells and tissues.
AlphaGenome can analyse up to one million DNA letters at once.
Researchers trained it on large public human and mouse genetics databases.
The tool helps pinpoint mutations linked to cancer, heart disease, and autoimmune disorders.
Scientists say it could accelerate drug discovery and future gene therapies.
Early users describe AlphaGenome as a major step forward in understanding the non-coding genome.